(2-(Benzyloxy)-4-(trifluoromethyl)phenyl)boronic acid, 98%, 25g

Vortioxetine hydrobromide, 97.0%, 100mg

[(2-fluoropyridin-3-yl)methyl](methyl)amine dihydrochloride, 1g

(R)-2-Amino-3-(4-fluorophenyl)-2-methylpropanoic acid, 95.0%, 250mg

8-Bromo-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 95%, 5g

(S)-2-Aminomethyl-1-N-Boc-piperidine, 96.0%, 250mg

Hexafluorocyclotriphosphazene, 97.0%, 1g

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-carboxylate, 98%, 250mg

Potassium dihydrogen phosphate, min. 98%, Ph.Eur., BP, 500 g, plastic packaging.

N1,N2-Dimethylphthalamide, 97%, 5g

N-Hydroxy-4-(2-methyl-thiazol-4-ylmethoxy)-benzamidine, 98%, 1g

(6-(Difluoromethoxy)pyridin-3-yl)boronic acid, 95.0%, 5g

ethyl 4-(4-cyanophenyl)-2-hydroxy-4-oxobut-2-enoate, 97%, 50mg